InsidersTradesSigma
Follow the ALTERITY THERAPEUTICS LIMITED share price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are quoted on AU AU, under the supervision of ASX. Market capitalisation: €132.7m. The latest transaction was disclosed on 29 June 2026 (Change in Substantial Holding). Among the most active insiders: listed in Annexure A (Group Entity),(together BNY). All data is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
ALTERITY THERAPEUTICS LIMITED is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases. It is listed on the XASX market.